Addiction Resource Center’s Experience Implementing Medication Assisted Treatment for Opiate Addiction The Business Case.

Slides:



Advertisements
Similar presentations
Care Coordinator Roles and Responsibilities
Advertisements

Alliance Clinic Mediation Assistant Tx Plus A New Program Design for Dual Diagnosis Patients Enhanced Treatment Program HONOR THE CHALLENGE - EMBRACE THE.
Role of the Pharmacist in Collaborative Care for Mental Health and Addiction Treatment in Medically Underserved Appalachia Sarah T. Melton, PharmD,BCPP,CGP.
Improving Continuation from Detox into Treatment – Advancing Recovery in Colorado Erik Stone, MS, CAC III Signal Behavioral Health Network Joseph Contreraz,
“The Phase I Group Attendance Project”.  To increase engagement in and completion of Phase I orientation groups within the Methadone Program.  Successful.
Addiction Resource Center’s Experience Marketing and Finding/Maximizing Revenue Sources for your Evidence Based Practices.
Swinomish Wellness Program
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
1 Reducing Waste and Improving Health Care Processes Through the Application of Lean Sheri Eisert, PhD Associate Professor University of Colorado Health.
August 2012 If you have an Emergency Department, you are in the Behavioral Health Business…..
Psychiatric Mental Health Nursing in Acute Care Settings.
Potential Barriers for HIV Medication Adherence Programs Wayne A. Duffus, MD, PhD June 21 st, 2010.
Program Development for Safety Net Institutions Catherine Deamant, MD Director, Palliative Care Services Cook County Health and Hospitals System Coleman.
Sutter Care Coordination Program (SCCP) Supporting Patients and Practitioners in Optimizing Health.
Care Plus NJ Center for Primary and Behavioral Health Care Plus NJ, Inc Cohort One Learning Community Region Five Paramus, New Jersey
Recovery Centers of King County Buprenorphine Treatment Program AAP Providers Conference, April 19, 2013, Lynnwood, WA Patricia C. Knox, Ph.D.
Care Coordination What is it? How Do We Get Started?
ADVANCING RECOVERY IN WEST VIRGINIA MEDICATION ASSISTED TREATMENT WITH BUPRENORPHINE/SUBOXONE AR LEVERS OF CHANGE JULY 2009.
Prestera Center The MAT recipe for continuation *MAT in 6 of 8 counties *827 active clients *Agency employs physicians that prescribe *Med Reviews done.
UCLA Integrated Substance Abuse Programs (ISAP). CSAT MTP Project Goals: To study the clinical effectiveness of the Matrix Model To study the clinical.
Maryland Cancer Plan Pain Management Committee Suzanne A Nesbit, PharmD, BCPS Clinical Coordinator, Cancer Pain Service Sidney Kimmel Comprehensive Cancer.
Attractive Addiction Treatment...? Can we make addiction treatment engaging?
1 Long-term Care Vermont’s Approach Individual Supports Unit Division of Disability and Aging Services Department of Disabilities, Aging & Independent.
BRANT COMMUNITY HEALTHCARE SYSTEM Mental Health and Addiction Services Brant Community Healthcare System November 2013 A Day Program is NOT a Day Hospital.
‘The courts and prisons’. The Courts: 1.Court Integrated Services Programs (C.I.S.P) 2.Court Referral & Evaluation for Drug Intervention & Treatment Program.
Initiating and Sustaining Mental Health Services in Primary Care Neil Korsen, MD, MSc Mary Jean Mork, LCSW April 16, 2009.
American Association for the Treatment of Opioid Dependence, Inc National Conference, Atlanta April 25, 2006 Evaluation of the Impact of Opioid Treatment.
Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Sophie Lanzkron, MD, MHS Associate Professor of Medicine and Oncology Johns Hopkins School of Medicine.
The Impact of Medicare Part D on Dual Eligible Psychiatric Patients’ Medication Access and Continuity.
Impact of the “Asthma Toolbox” for Improving Documentation of Pediatric Asthma Management in an Urban Community Health Center Presenter: Delaney Gracy,
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Reduce Waiting & No-Shows  Increase Admissions & Continuation Overview CO HIV-STIC NIATx Kick-off Training November 8, 2011 Colorado Springs,
Baltimore Buprenorphine Initiative Advancing Recovery Project Baltimore City, Maryland January 14, 2010.
III. Affect of the 2011 duty hour regulations on the source of admission Harborview Medical Center primary team
Expanding Authority for MAT, New Initiatives and Next Steps Brad DeCamp SOTA Ohio Mental Health & Addiction Services.
Accelerating Reform Initiative Developing Integrated care: Fayette Companies and Heartland Community Health Center Mike Bolye.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Addiction Resource Center’s Experience Implementing Medication Assisted Treatment Eric Haram, LADC Director OPBH-Mid Coast Hospital Niatx Coach.
MAT Funding Approaches Linda J. Frazier, RN, CHES, MA Treatment Manager Maine Office of Substance Abuse, DHHS.
Pharmacy 483 Outcomes & Cost Management in Pharmacy Practice Janet Kelly, Pharm.D., BC-ADM February 24, 2004.
Reduce Waiting & No-Shows  Increase Admissions & Continuation Who are We? We are: –Jefferson County, Alabama, Drug Court –Beacon Addiction.
The Consumer’s Role in Whole Systems Change Linda J. Frazier, RN, CHES, MA Treatment Manager Maine Office of Substance Abuse, DHHS.
Addiction Resource Center’s Experience Implementing Medication Assisted Treatment for Opiate Addiction The Business Case.
Cultural Competency and Patient Satisfaction: A Pilot Training Project September 24, th National Conference on Quality Health Care for Culturally.
Reducing Readmissions Providing Home Health Services to the vulnerable population.
Ten Years of Pharmacotherapy Trials in the CTN: An Overview.
Using the NIATx 5x5 Presentation Model
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
Kings County Hospital Center MATP III NIATX PROCESS IMPROVEMENT PROJECT APR – NOV 2011 Our Change Team Executive Sponsor : Janet Aiyeku (Sr. Executive.
Risk Management of Modified- Release Opiate Analgesics: Palladone Sharon Hertz, M.D. Medical Team Leader, Analgesics Division of Anesthetic, Critical Care,
Universal Counseling Services Baltimore, Maryland.
Reduce Waiting & No-Shows  Increase Admissions & Continuation Reduce Waiting & No-Shows  Increase Admissions & Continuation Lynn M Madden,
Medication Assisted Treatment Adding a new medication into outpatient treatment.
Nova Center for Youth and Family Huntsville, AL Gina Koger, LGSW - Director Susan Smith, LPC – Program Mgr.
REDUCING ANTIBIOTIC OVERUSE for ARIs with SMALL- GROUP EDUCATIONAL INTERVENTION Munawaroh S 1, Sunartono H 2, Suryawati S 3 1 INRUD Yogya/Indonesia; 2.
Spectrum Health Systems Lincoln Street Opiate Treatment Program Support for this project was provided by NIATx through a grant from the National Institute.
Care Coordination Collaborative Change Package Visual February 21, 2014.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Medication Assisted Treatment
Brian C. Martin, Ph.D., MBA East Tennessee State University
Defining Best Practice:
Medication assisted treatment
Case Rate Toolkit Measuring Value Payment Models Health Home Rates
Vision Transformative collaboration that fosters resilient self-sustaining Recovery Communities. Mission To develop and sustain measurable solutions that.
Medically assisted treatment
Medication Assisted Treatment of Opioid Use Disorder
Transforming the Delivery of Substance Use Disorder Treatment in States Update August 2019.
Presentation transcript:

Addiction Resource Center’s Experience Implementing Medication Assisted Treatment for Opiate Addiction The Business Case

ARC MAT Services Two locations. Brunswick-140 pts. 28 hrs. of MD Time, 4 MAT Grps./ wk. Damariscotta- 90 pts. 16 hrs. of MD Time, 3 MAT Grps./wk. Two locations. Brunswick-140 pts. 28 hrs. of MD Time, 4 MAT Grps./ wk. Damariscotta- 90 pts. 16 hrs. of MD Time, 3 MAT Grps./wk. MAT Program has 4 levels and pts. are in tx. anywhere in the continuum of care. MAT Program has 4 levels and pts. are in tx. anywhere in the continuum of care. MD and Tx. Counselors Co-Facilitate MAT grps. MD and Tx. Counselors Co-Facilitate MAT grps. Billed primarily as 99212’s (10 Min. Est. Pt.- Eval. and Management) Billed primarily as 99212’s (10 Min. Est. Pt.- Eval. and Management) 10 inductions per week, 5 Detox Transfers per week. 10 inductions per week, 5 Detox Transfers per week.

Community Response-Mission Fit ARC took a 4 month snap shot to trend volumes of clients seeking treatment for opiate dependence. ARC took a 4 month snap shot to trend volumes of clients seeking treatment for opiate dependence. On average callers per month request Suboxone assisted treatment. On average callers per month request Suboxone assisted treatment. Of 15 assessments Dx. with opioid dependence in Jan. and Feb Of 15 assessments Dx. with opioid dependence in Jan. and Feb Five have admitted to treatment programs and are involved in MAT. Five have admitted to treatment programs and are involved in MAT. Those not admitted did not access MAT Those not admitted did not access MAT Anticipated volume of new ARC clients per year is clients Anticipated volume of new ARC clients per year is clients

Community Response-Mission Fit

Community Response-Business Case The 115 patients treated by programs in Westbrook equate to the current volume of ARC Intensive Outpatient Programs (IOP). The 115 patients treated by programs in Westbrook equate to the current volume of ARC Intensive Outpatient Programs (IOP). Absorbing this volume equates to an additional 2,300 IOP treatment days per year for ARC. Absorbing this volume equates to an additional 2,300 IOP treatment days per year for ARC. The funding mix from this population is: The funding mix from this population is: 34% private insurance 28% Medicaid 17% Medicare 16% Unfunded

Post Implementation Access/Increased Admissions Access to Buprenorphine services has sustained a 20% increase in New Business. Access to Buprenorphine services has sustained a 20% increase in New Business.

Business Case MAT Groups Used PDCA cycles to pilot one group for 8 wks. Used PDCA cycles to pilot one group for 8 wks. Better use of multidisciplinary team approach Better use of multidisciplinary team approach Consistent application of standard of care Consistent application of standard of care Replicate intervention with two 1.5 hour groups per week. Replicate intervention with two 1.5 hour groups per week. 2 groups per week takes 12 hours per month vs hours per month for MD to see same case load individually. 2 groups per week takes 12 hours per month vs hours per month for MD to see same case load individually. 2 groups per week absorbs 112 encounters per month. 2 groups per week absorbs 112 encounters per month. Increase monthly average from 8 to 16 inductions. Increase monthly average from 8 to 16 inductions. Increase monthly average from 2 to 7 psychiatric evaluations. Increase monthly average from 2 to 7 psychiatric evaluations. Will result in increase revenues in the amount of $41, per year-NET. Will result in increase revenues in the amount of $41, per year-NET.

Business Case-Room to Breathe Greater self-reliance during times of social service cuts and legislative unpredictability. Greater self-reliance during times of social service cuts and legislative unpredictability. In spite of flat funding, ARC has reduced the percentage it is underwritten by state dollars from 60% in SFY 06 to 42% in SFY 09. In spite of flat funding, ARC has reduced the percentage it is underwritten by state dollars from 60% in SFY 06 to 42% in SFY 09.

Key System Changes Integrate suboxone services within ARC continuum of care. Integrate suboxone services within ARC continuum of care. Bring physicians on-site, single standard of care, improve communication, decrease staff load. Bring physicians on-site, single standard of care, improve communication, decrease staff load. Working with recovery community to change attitudes. Working with recovery community to change attitudes. Focus groups, presentations, well clients. Focus groups, presentations, well clients. Maximize billing as the result of State/Payer change projects. Maximize billing as the result of State/Payer change projects. Work with the Maine formulary committee to reduce stigma and assure access to buprenorphine products. Work with the Maine formulary committee to reduce stigma and assure access to buprenorphine products.

Diversion Concern about diversion and misuse of buprenorphine must be seen in the context of rampant opioid diversion and misuse (see S. Okie, “A flood of opiates, a rising tide of death,” N Engl J of Med, 363;21, Concern about diversion and misuse of buprenorphine must be seen in the context of rampant opioid diversion and misuse (see S. Okie, “A flood of opiates, a rising tide of death,” N Engl J of Med, 363;21,

Efforts to reduce impact of opiate addiction on public health and safety: Pt. Adherence Twice weekly clinical huddles to review cases and develop timely interventions. Twice weekly clinical huddles to review cases and develop timely interventions. Rigorous use of Prescription Monitoring Database. Rigorous use of Prescription Monitoring Database. Random, observed UDS may include Buprenorphine levels. Random, observed UDS may include Buprenorphine levels. Random pill counts Random pill counts

Efforts to reduce impact of opiate addiction on public health and safety: Pt. Adherence ARC took a snapshot of 20 pt. pill counts conducted prior to attendance at group as a baseline measure of medication adherence. The second sample was with all patients using bubble packs. The adherence rates with bubble packs was double the baseline measure. ARC took a snapshot of 20 pt. pill counts conducted prior to attendance at group as a baseline measure of medication adherence. The second sample was with all patients using bubble packs. The adherence rates with bubble packs was double the baseline measure. ARC has requested that all participating pharmacies use bubble packing for Bup. only. As of Jan. 1, 2011 all participating pharmacies use bubble packs. ARC has requested that all participating pharmacies use bubble packing for Bup. only. As of Jan. 1, 2011 all participating pharmacies use bubble packs. 25% of the ARC MAT clients have random pill counts weekly. This rotates as planned in clinical huddles to assure monthly random counts for each pt. each month. 25% of the ARC MAT clients have random pill counts weekly. This rotates as planned in clinical huddles to assure monthly random counts for each pt. each month.

 Payer/Provider Partnerships Support for rapid cycle change approach. Support for rapid cycle change approach. State wants to know barriers to MAT implementation. State wants to know barriers to MAT implementation. Access Access Flexibility Flexibility Advocacy and Credibility Advocacy and Credibility Operational relief Operational relief Licensing regulations Licensing regulations Incentives in Contracting are congruent with 4 AIMS Incentives in Contracting are congruent with 4 AIMS